What is aTyr Pharma's AOCI?

aTyr Pharma (ATYR) reported AOCI of -$70K in Q1 2026.

How has aTyr Pharma's AOCI changed year-over-year?

aTyr Pharma's AOCI decreased by 6.1% year-over-year, from -$66K to -$70K.

What is the long-term trend for aTyr Pharma's AOCI?

Over 5 years (2020 to 2025), aTyr Pharma's AOCI has grown at a -28.6% compound annual growth rate (CAGR), from -$43K to -$8K.

Accumulated gains and losses bypassing the income statement — unrealized investment gains/losses, currency translation, pension adjustments, and hedge results.

aTyr Pharma ATYR AOCI

AOCI at other companies

Bristol-Myers SquibbBMY

-$1.37B+3.8%

Merck & Co.MRK

-$4.06B+18.2%

United TherapeuticsUTHR

-$10.2M-750%

Design Therapeutics, Inc.DSGN

-$268K-160%

CytomX TherapeuticsCTMX

$102K+10,300%

Vor BiopharmaVOR

-$706K-3,170%

Other financials

Income statement

See full

Revenue-—

Operating income-$11.4M+27.5%

Net income-$10.8M+27.5%

EPS (diluted)-$0.11+35.3%

Balance sheet

See full

Cash & equivalents$10.0M-3.4%

Total debt$12.3M-9.2%

Total equity$57.9M-22.8%

Total assets$79.7M-18.1%

Cash flow

See full

Operating cash flow-$12.5M+18.8%

CapEx$138.0K—

Free cash flow-$12.7M+17.9%

Valuation

See full

Market cap$54.88M-88.2%

Enterprise value$57.17M—

P/S288.8×—

Profitability

See full

Operating margin-40,856.3%+28,833pp

Net margin-39,009.5%+29,653pp

FCF margin-32,664.7%+4,018pp

Returns & leverage

See full

Return on equity-105.3%+50.6pp

Debt / equity0.2×0.0×

Current ratio5.8×-2.0×

Where this comes from

Reported directly by aTyr Pharma in its filing.

Tagged under the XBRL concept us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax.

The official record: aTyr Pharma’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about aTyr Pharma's aoci.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is aTyr Pharma's AOCI?: aTyr Pharma (ATYR) reported AOCI of -$70K in Q1 2026.
How has aTyr Pharma's AOCI changed year-over-year?: aTyr Pharma's AOCI decreased by 6.1% year-over-year, from -$66K to -$70K.
What is the long-term trend for aTyr Pharma's AOCI?: Over 5 years (2020 to 2025), aTyr Pharma's AOCI has grown at a -28.6% compound annual growth rate (CAGR), from -$43K to -$8K.
What does AOCI mean?: Accumulated gains and losses bypassing the income statement — unrealized investment gains/losses, currency translation, pension adjustments, and hedge results.